Jiří Tomášek

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Charles S. Fuchs, Jiří Tomášek, Filip Dumitru et al. · The Lancet · 2013 · 2.2K citations · Full text

Surgical Oncology, Esophageal Cancer, Gastrointestinal Oncology +11

Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study

James C. Yao, Nicola Fazio, Simron Singh et al. · The Lancet · 2015 · 1.2K citations

Oncology, Gastrointestinal Oncology, Medicine +8

Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial

Robert J. Motzer, Thomas E. Hutson, Hilary Glen et al. · The Lancet Oncology · 2015 · 929 citations

Urology, Genitourinary Cancer, Medicine +4

Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study

Arvind Dasari, Sara Lonardi, Rocio García‐Carbonero et al. · The Lancet · 2023 · 279 citations · Full text

Oncology, Gastrointestinal Oncology, Colorectal Cancer +6

Everolimus in advanced, progressive, well‐differentiated, non‐functional neuroendocrine tumors: <scp>RADIANT</scp>‐4 lung subgroup analysis

Nicola Fazio, Roberto Buzzoni, Gianfranco Delle Fave et al. · Cancer Science · 2017 · 97 citations · Full text